CARBOPROST TROMETHAMINE

CARBOPROST TROMETHAMINE was reported 734 times

CARBOPROST TROMETHAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LOCHIAL INFECTION 1 0.1111
1 AMNIOTIC FLUID EMBOLUS 1 0.1111
2 PUERPERAL INFECTION 1 0.0500
3 UTERINE INVERSION 1 0.0455
4 CAROTID ANEURYSM RUPTURE 1 0.0270
5 POST PROCEDURAL PERSISTENT DRAIN FLUID 1 0.0217
6 ANAPHYLACTOID SYNDROME OF PREGNANCY 2 0.0208
7 ACUTE OESOPHAGEAL MUCOSAL LESION 1 0.0182
8 EPIDURAL ANAESTHESIA 1 0.0179
9 PYOMETRA 1 0.0143
10 VACUUM EXTRACTOR DELIVERY 1 0.0119
11 UTERINE TENDERNESS 1 0.0116
12 LABOUR PAIN 1 0.0110
13 ECLAMPSIA 4 0.0109
14 ELECTROCARDIOGRAM Q WAVES 1 0.0098
15 PRODUCT DESIGN CONFUSION 1 0.0097
16 POSTPARTUM DISORDER 1 0.0093
17 VAGINAL LACERATION 2 0.0092
18 RUBELLA 1 0.0088
19 INTRACRANIAL INFECTION 1 0.0080
20 UTERINE HYPOTONUS 1 0.0079
21 UTERINE ATONY 2 0.0076
22 INTRAUTERINE INFECTION 1 0.0074
23 HYPOTHERMIA NEONATAL 1 0.0070
24 PERINEAL INJURY 1 0.0066
25 NEONATAL TACHYCARDIA 1 0.0065
26 PERIPARTUM CARDIOMYOPATHY 1 0.0058
27 GASTROINTESTINAL MALFORMATION 1 0.0048
28 SUPERFICIAL VEIN THROMBOSIS 4 0.0048
29 ANORECTAL SWELLING 1 0.0044
30 ARRESTED LABOUR 1 0.0042
31 AIRWAY COMPLICATION OF ANAESTHESIA 1 0.0038
32 UTERINE HYPERTONUS 1 0.0037
33 SUSPECTED OFF LABEL USE 15 0.0033
34 THERAPEUTIC EMBOLISATION 1 0.0032
35 POSTPARTUM HAEMORRHAGE 4 0.0030
36 ANION GAP DECREASED 1 0.0029
37 SUFFOCATION FEELING 7 0.0028
38 HEART VALVE STENOSIS 1 0.0028
39 ORAL DISCHARGE 1 0.0027
40 LIVIDITY 1 0.0027
41 ACCELERATED HYPERTENSION 1 0.0026
42 TRISOMY 18 1 0.0026
43 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
44 VASOCONSTRICTION 2 0.0023
45 OPERATIVE HAEMORRHAGE 1 0.0022
46 PRODUCT APPEARANCE CONFUSION 2 0.0022
47 TACHYCARDIA FOETAL 1 0.0020
48 ORBITAL OEDEMA 1 0.0020
49 TRACHEAL DISORDER 1 0.0019
50 ANAL INCONTINENCE 16 0.0018
51 DYSPHORIA 9 0.0018
52 TACHYPNOEA 24 0.0018
53 PO2 DECREASED 2 0.0017
54 RESPIRATORY TRACT HAEMORRHAGE 1 0.0017
55 LARYNGEAL DISCOMFORT 1 0.0016
56 INCREASED BRONCHIAL SECRETION 4 0.0016
57 ENDOMETRITIS 1 0.0015
58 SPUTUM INCREASED 3 0.0014
59 GASTRIC MUCOSAL LESION 1 0.0014
60 OXYGEN SUPPLEMENTATION 1 0.0014
61 LOCAL REACTION 1 0.0013
62 HEART SOUNDS ABNORMAL 1 0.0013
63 INDIFFERENCE 1 0.0013
64 ELECTROMECHANICAL DISSOCIATION 1 0.0013
65 PRODUCT PACKAGING CONFUSION 3 0.0012
66 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
67 INFANTILE APNOEA 1 0.0012
68 NEONATAL HYPOXIA 1 0.0012
69 STARVATION 1 0.0012
70 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
71 LARYNGOSPASM 3 0.0011
72 MUSCLE NECROSIS 1 0.0011
73 PELVIC DISCOMFORT 1 0.0011
74 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
75 UTERINE PAIN 1 0.0010
76 TEMPERATURE INTOLERANCE 10 0.0010
77 CHEST DISCOMFORT 95 0.0009
78 PRODUCT SELECTION ERROR 1 0.0009
79 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
80 CATHETER RELATED COMPLICATION 1 0.0009
81 DILATATION ATRIAL 1 0.0009
82 BRONCHOSPASM 12 0.0008
83 PRETERM PREMATURE RUPTURE OF MEMBRANES 1 0.0008
84 ENCEPHALITIS VIRAL 1 0.0008
85 RECTAL TENESMUS 1 0.0008
86 TACHYARRHYTHMIA 2 0.0008
87 GESTATIONAL HYPERTENSION 1 0.0008
88 SINUS ARRHYTHMIA 1 0.0008
89 RHONCHI 1 0.0007
90 UTERINE HAEMORRHAGE 3 0.0007
91 MENTAL FATIGUE 1 0.0007
92 HYPOTONIA NEONATAL 1 0.0006
93 TRANSCRIPTION MEDICATION ERROR 1 0.0006
94 OPTIC NERVE DISORDER 1 0.0006
95 LISTLESS 2 0.0006
96 OXYGEN SATURATION DECREASED 32 0.0006
97 RESPIRATORY RATE INCREASED 5 0.0006
98 INTERCEPTED PRODUCT STORAGE ERROR 2 0.0006
99 OROPHARYNGEAL DISCOMFORT 5 0.0006
100 VENTRICULAR ARRHYTHMIA 2 0.0005
101 DISORGANISED SPEECH 1 0.0005
102 INJECTION SITE CELLULITIS 1 0.0005
103 ACUTE PULMONARY OEDEMA 3 0.0005
104 NASAL OBSTRUCTION 1 0.0005
105 MECHANICAL VENTILATION 1 0.0005
106 COLD SWEAT 9 0.0005
107 HYPERAEMIA 1 0.0005
108 ABDOMINAL PAIN UPPER 102 0.0005
109 FOAMING AT MOUTH 1 0.0005
110 VENOUS THROMBOSIS LIMB 1 0.0005
111 VOMITING 224 0.0005
112 DILATATION VENTRICULAR 1 0.0005
113 DISCOMFORT 29 0.0005
114 SENSATION OF FOREIGN BODY 4 0.0005
115 HYPERPYREXIA 2 0.0005
116 GASTROINTESTINAL PAIN 5 0.0005
117 GASTROINTESTINAL DISORDER 40 0.0004
118 RASH ERYTHEMATOUS 21 0.0004
119 PRE-ECLAMPSIA 2 0.0004
120 GASTROINTESTINAL OBSTRUCTION 1 0.0004
121 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
122 PANNICULITIS 1 0.0004
123 BLOOD PRESSURE INCREASED 63 0.0004
124 ABDOMINAL DISCOMFORT 69 0.0004
125 INJECTION SITE ABSCESS 1 0.0004
126 HYPERTHERMIA 3 0.0004
127 BODY TEMPERATURE INCREASED 8 0.0004
128 VENTRICULAR DYSFUNCTION 1 0.0004
129 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
130 RETCHING 8 0.0004
131 GASTROINTESTINAL INJURY 1 0.0004
132 NORMAL NEWBORN 2 0.0004
133 ENDOTRACHEAL INTUBATION 1 0.0004
134 PALPITATIONS 41 0.0003
135 VOMITING PROJECTILE 1 0.0003
136 RALES 2 0.0003
137 STRIDOR 1 0.0003
138 CEREBROVASCULAR DISORDER 1 0.0003
139 PALLOR 9 0.0003
140 CRANIOCEREBRAL INJURY 1 0.0003
141 HYPERHIDROSIS 41 0.0003
142 CYANOSIS 5 0.0003
143 SINUS BRADYCARDIA 3 0.0003
144 POOR QUALITY DRUG ADMINISTERED 2 0.0003
145 ABDOMINAL PAIN 71 0.0003
146 NEAR DEATH EXPERIENCE 1 0.0003
147 HEART RATE INCREASED 29 0.0003
148 REGURGITATION 1 0.0003
149 MICTURITION DISORDER 1 0.0003
150 HYPERREFLEXIA 1 0.0003
151 DEFAECATION URGENCY 2 0.0003
152 PAPULE 2 0.0003
153 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
154 FIBRIN D DIMER INCREASED 1 0.0003
155 VISUAL FIELD DEFECT 2 0.0003
156 EPIGASTRIC DISCOMFORT 1 0.0003
157 PROCEDURAL HAEMORRHAGE 1 0.0003
158 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
159 NAUSEA 199 0.0003
160 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
161 ANAPHYLACTOID REACTION 1 0.0002
162 FLUSHING 24 0.0002
163 TENSION HEADACHE 1 0.0002
164 HYSTERECTOMY 2 0.0002
165 MONOPLEGIA 1 0.0002
166 ILEUS PARALYTIC 1 0.0002
167 DIARRHOEA 144 0.0002
168 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
169 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
170 FEELING COLD 6 0.0002
171 DIARRHOEA HAEMORRHAGIC 2 0.0002
172 YELLOW SKIN 1 0.0002
173 PULSE ABSENT 1 0.0002
174 ACUTE RESPIRATORY FAILURE 4 0.0002
175 ENTEROCOCCAL INFECTION 1 0.0002
176 BREATH SOUNDS ABNORMAL 1 0.0002
177 HYPERVOLAEMIA 1 0.0002
178 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
179 SALIVARY HYPERSECRETION 2 0.0002
180 HYPOAESTHESIA ORAL 3 0.0002
181 ABDOMINAL PAIN LOWER 5 0.0002
182 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
183 BLOOD PRESSURE DECREASED 13 0.0002
184 INJECTION SITE RASH 6 0.0002
185 PHLEBITIS 1 0.0002
186 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
187 ANAPHYLACTIC SHOCK 5 0.0002
188 MUSCULOSKELETAL CHEST PAIN 3 0.0002
189 TRISMUS 1 0.0002
190 VENTRICULAR EXTRASYSTOLES 2 0.0002
191 PRODUCTIVE COUGH 9 0.0002
192 ANORECTAL DISCOMFORT 1 0.0002
193 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
194 BRUXISM 1 0.0002
195 FAECES DISCOLOURED 4 0.0002
196 TIC 1 0.0002
197 MENTAL STATUS CHANGES 5 0.0002
198 CIRCULATORY COLLAPSE 3 0.0002
199 MUSCLE TWITCHING 4 0.0002
200 HYPERCHLORHYDRIA 1 0.0002
201 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
202 OFF LABEL USE 144 0.0002
203 LARYNGEAL OEDEMA 1 0.0002
204 OLIGURIA 1 0.0002
205 EXPOSURE DURING PREGNANCY 10 0.0002
206 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
207 CHILLS 18 0.0002
208 FEEDING DISORDER 3 0.0001
209 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
210 RESPIRATION ABNORMAL 1 0.0001
211 RIGHT VENTRICULAR FAILURE 1 0.0001
212 SINUS TACHYCARDIA 2 0.0001
213 PRODUCT SUPPLY ISSUE 1 0.0001
214 GASTROENTERITIS 2 0.0001
215 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
216 TACHYCARDIA 12 0.0001
217 BLOOD POTASSIUM DECREASED 4 0.0001
218 ATRIOVENTRICULAR BLOCK 1 0.0001
219 DELUSION 2 0.0001
220 APNOEA 1 0.0001
221 TRICUSPID VALVE INCOMPETENCE 1 0.0001
222 LOW BIRTH WEIGHT BABY 1 0.0001
223 PREMATURE DELIVERY 2 0.0001
224 ATRIAL FLUTTER 1 0.0001
225 SHOCK HAEMORRHAGIC 1 0.0001
226 ABNORMAL FAECES 1 0.0001
227 LIVE BIRTH 1 0.0001
228 SKIN PLAQUE 1 0.0001
229 DYSPNOEA 67 0.0001
230 ANURIA 1 0.0001
231 SKIN SWELLING 1 0.0001
232 URINE OUTPUT DECREASED 1 0.0001
233 HEART RATE DECREASED 4 0.0001
234 RESPIRATORY DISTRESS 3 0.0001
235 ERYTHEMA MULTIFORME 1 0.0001
236 PRODUCT USE ISSUE 20 0.0001
237 ABDOMINAL DISTENSION 11 0.0001
238 INJECTION SITE ERYTHEMA 13 0.0001
239 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
240 AFFECT LABILITY 1 0.0001
241 GLAUCOMA 2 0.0001
242 VAGINAL DISCHARGE 1 0.0001
243 SUBARACHNOID HAEMORRHAGE 1 0.0001
244 NEUTROPHIL COUNT INCREASED 1 0.0001
245 INITIAL INSOMNIA 1 0.0001
246 SWOLLEN TONGUE 3 0.0001
247 PULMONARY HYPERTENSION 2 0.0001
248 INJECTION SITE DISCOMFORT 1 0.0001
249 HYPERTENSION 20 0.0001
250 LIP SWELLING 3 0.0001
251 VENTRICULAR FIBRILLATION 1 0.0001
252 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
253 PRURITUS 34 0.0001
254 IMPAIRED DRIVING ABILITY 1 0.0001
255 MYOCARDIAL ISCHAEMIA 1 0.0001
256 SHOCK 2 0.0001
257 EYELID OEDEMA 1 0.0001
258 CAESAREAN SECTION 1 0.0001
259 BACTERAEMIA 1 0.0001
260 MUSCLE RIGIDITY 1 0.0001
261 ERYTHEMA 17 0.0001
262 NO THERAPEUTIC RESPONSE 1 0.0001
263 RESTLESSNESS 3 0.0001
264 RESPIRATORY DEPRESSION 1 0.0001
265 FEELING HOT 5 0.0001
266 INJECTION SITE URTICARIA 2 0.0001
267 INJECTION SITE SWELLING 6 0.0001
268 INJECTION SITE INDURATION 1 0.0001
269 ADVERSE REACTION 1 0.0001
270 COUGH 21 0.0001
271 DIZZINESS 37 0.0001
272 FREQUENT BOWEL MOVEMENTS 2 0.0001
273 BLOOD TEST ABNORMAL 1 0.0001
274 DYSPEPSIA 7 0.0001
275 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
276 SKIN REACTION 1 0.0001
277 PARALYSIS 1 0.0001
278 PSYCHOTIC DISORDER 2 0.0001
279 WHEEZING 4 0.0001
280 PULMONARY OEDEMA 3 0.0001
281 THROAT IRRITATION 3 0.0001
282 HYPOAESTHESIA 10 0.0001
283 BLOOD COUNT ABNORMAL 1 0.0001
284 EJECTION FRACTION DECREASED 1 0.0001
285 ARRHYTHMIA 3 0.0001
286 PYREXIA 21 0.0001
287 HEADACHE 38 0.0001
288 SEIZURE 7 0.0001
289 CARDIAC ARREST 5 0.0001
290 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
291 RASH 26 0.0001
292 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
293 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
294 MULTI-ORGAN FAILURE 1 0.0001
295 SPEECH DISORDER 3 0.0001
296 RASH MACULAR 2 0.0001
297 HYPOXIA 2 0.0001
298 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
299 DRUG ERUPTION 1 0.0001
300 THIRST 1 0.0001
301 ASTHENIA 21 0.0001
302 AGITATION 4 0.0001
303 ANAPHYLACTIC REACTION 3 0.0001
304 URTICARIA 9 0.0001
305 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
306 POST PROCEDURAL COMPLICATION 1 0.0001
307 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
308 PREGNANCY 1 0.0000
309 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
310 VERTIGO 3 0.0000
311 INJECTION SITE WARMTH 1 0.0000
312 TREMOR 8 0.0000
313 HAEMORRHAGE 5 0.0000
314 LIVER FUNCTION TEST INCREASED 1 0.0000
315 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
316 VAGINAL HAEMORRHAGE 2 0.0000
317 SWELLING FACE 3 0.0000
318 MENTAL DISORDER 2 0.0000
319 PRODUCT PRESCRIBING ISSUE 1 0.0000
320 RASH PAPULAR 1 0.0000
321 THERAPY NON-RESPONDER 2 0.0000
322 CHEST PAIN 8 0.0000
323 HYPERSENSITIVITY 8 0.0000
324 SWELLING 4 0.0000
325 COMA 2 0.0000
326 BLOOD PRESSURE FLUCTUATION 1 0.0000
327 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
328 EXTRAPYRAMIDAL DISORDER 1 0.0000
329 HAEMATEMESIS 1 0.0000
330 MUSCULOSKELETAL PAIN 2 0.0000
331 DEPRESSED MOOD 2 0.0000
332 INJECTION SITE BRUISING 3 0.0000
333 INJECTION SITE HAEMORRHAGE 3 0.0000
334 THROAT TIGHTNESS 1 0.0000
335 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
336 RESPIRATORY ARREST 1 0.0000
337 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
338 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
339 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
340 URINARY INCONTINENCE 1 0.0000
341 PREMATURE BABY 1 0.0000
342 LACRIMATION INCREASED 1 0.0000
343 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
344 EPILEPSY 1 0.0000
345 MUSCLE SPASMS 6 0.0000
346 DRUG ADMINISTRATION ERROR 1 0.0000
347 PULMONARY EMBOLISM 3 0.0000
348 METABOLIC ACIDOSIS 1 0.0000
349 NIGHT SWEATS 1 0.0000
350 SYNCOPE 3 0.0000
351 SKIN DISORDER 1 0.0000
352 HYPOTENSION 6 0.0000
353 GASTRIC DISORDER 1 0.0000
354 VISION BLURRED 4 0.0000
355 BURNING SENSATION 2 0.0000
356 CEREBRAL HAEMORRHAGE 1 0.0000
357 MYELOSUPPRESSION 1 0.0000
358 CRYING 1 0.0000
359 CONFUSIONAL STATE 4 0.0000
360 DRY MOUTH 2 0.0000
361 TREATMENT FAILURE 2 0.0000
362 PRODUCT QUALITY ISSUE 3 0.0000
363 SKIN DISCOLOURATION 1 0.0000
364 HYPOKALAEMIA 1 0.0000
365 CARDIAC DISORDER 2 0.0000
366 HYPOGLYCAEMIA 1 0.0000
367 LUNG DISORDER 1 0.0000
368 AGGRESSION 1 0.0000
369 HAEMOGLOBIN DECREASED 2 0.0000
370 PANCREATITIS 1 0.0000
371 BRADYCARDIA 1 0.0000
372 DISTURBANCE IN ATTENTION 1 0.0000
373 RASH PRURITIC 1 0.0000
374 HAEMATOCHEZIA 1 0.0000
375 MEDICATION ERROR 1 0.0000
376 ASTHMA 2 0.0000
377 FLATULENCE 1 0.0000
378 MUSCULAR WEAKNESS 2 0.0000
379 DRUG INEFFECTIVE 23 0.0000
380 HERPES ZOSTER 1 0.0000
381 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
382 DYSPHONIA 1 0.0000
383 ILL-DEFINED DISORDER 1 0.0000
384 INJECTION SITE PAIN 5 0.0000
385 LOSS OF CONSCIOUSNESS 2 0.0000
386 DEEP VEIN THROMBOSIS 1 0.0000
387 AMNESIA 1 0.0000
388 INJECTION SITE REACTION 1 0.0000
389 INJURY 1 0.0000
390 HALLUCINATION 1 0.0000
391 HOT FLUSH 1 0.0000
392 PARAESTHESIA 2 0.0000
393 CARDIAC FAILURE 1 0.0000
394 THROMBOSIS 1 0.0000
395 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
396 MUSCULOSKELETAL STIFFNESS 1 0.0000
397 ANAEMIA 2 0.0000
398 MIGRAINE 1 0.0000
399 SOMNOLENCE 2 0.0000
400 PLATELET COUNT DECREASED 1 0.0000
401 SEPSIS 1 0.0000
402 THROMBOCYTOPENIA 1 0.0000
403 DECREASED APPETITE 2 0.0000
404 JOINT SWELLING 1 0.0000
405 EMOTIONAL DISTRESS 1 0.0000
406 OEDEMA PERIPHERAL 1 0.0000
407 RENAL FAILURE 1 0.0000
408 DEHYDRATION 1 0.0000
409 DRY SKIN 1 0.0000
410 CONDITION AGGRAVATED 2 0.0000
411 ACUTE KIDNEY INJURY 1 0.0000
412 PAIN 4 0.0000
413 PERIPHERAL SWELLING 1 0.0000
414 DRUG DOSE OMISSION 1 0.0000
415 TOXICITY TO VARIOUS AGENTS 1 0.0000
416 MYALGIA 1 0.0000
417 NASOPHARYNGITIS 1 0.0000
418 FATIGUE 4 0.0000
419 OVERDOSE 1 0.0000
420 BACK PAIN 1 0.0000
421 FEELING ABNORMAL 1 0.0000
422 ANXIETY 1 0.0000
423 PAIN IN EXTREMITY 1 0.0000
424 ARTHRALGIA 1 0.0000